Supernus Pharmaceuticals saw the highest growth of 0.99% in patent filings and 3.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 3.99%. GlobalData’s DataBook provides a comprehensive analysis of Supernus Pharmaceuticals’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Supernus Pharmaceuticals has been focused on protecting inventions in European Patent Office(EPO) with two publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent grants with nearly 20% of grants. The United States(US), Chile(CL), European Patent Office(EPO), and Australia(AU) patent Office are among the top ten patent offices where Supernus Pharmaceuticals is filings its patents. Among the top granted patent authorities, Supernus Pharmaceuticals has 20% of its grants in European Patent Office(EPO), 20% in United States(US) and 20% in Australia(AU).
Roche could be the strongest competitor for Supernus Pharmaceuticals
Epilepsy related patents lead Supernus Pharmaceuticals portfolio followed by emesis (vomiting), and nausea
Supernus Pharmaceuticals has highest number of patents in epilepsy followed by emesis (vomiting), nausea, petrochemicals, and multiple sclerosis.
For comprehensive analysis of Supernus Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
